WARSAW – OrthoWorx, the organization dedicated to sustaining and expanding Warsaw’s role as the Orthopedic Capital of the Word, announced on Tuesday, Aug. 24, a leadership transition.
Effective Sept. 1, Brad Bishop will retire as OrthoWorx executive director and will be replaced by Matthew Hall, who will serve as Interim Executive Director.
Bishop has been with OrthoWorx for more than 11 years and was integral in the organization’s launch and has served as a key executive since joining as its first employee.
Hall, who has served as an outside advisor to the OrthoWorx Board of Directors as well as a consultant for AcceLINX, the medical device business accelerator launched by OrthoWorx, was pivotal in the launch of OrthoWorx in 2009. At that time, he was with BioCrossroads, the statewide life sciences initiative that managed the study that led to the formation of OrthoWorx.
“As we develop a strategic plan for the future of OrthoWorx, we are grateful that Brad has stayed with us past his planned retirement date in order to get us to the point where we can make this transition and prepare for our future,” said David Findlay, President and CEO of Lake City Bank and OrthoWorx board chairman.
“Brad has been a key contributor to the many successes that OrthoWorx has achieved, and we are very grateful to him for his unselfish service.” Findlay continued, “And we feel very fortunate that Matt, who has deep experience with the medical device cluster and its players, is willing to take on the important work of plotting the next phase of the OrthoWorx initiative.”
As interim executive director, Hall will be responsible for the management of OrthoWorx and for developing a new strategic plan for the organization. “The medical device industry cluster centered around Warsaw is a significant driver of Indiana’s economy overall and is critical to the economic vitality and regional employment of northeast Indiana,” said Hall. “I look forward to working with the board and staff to assure that we retain this unrivaled position in the global medical device industry.”